Latest Feature

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Medicare's Sunshine Act changes could hit device makers in the pocketbook

July 22, 2014 by Arezu Sarvestani

The Centers for Medicare & Medicaid Services proposes 4 changes to physician payment transparency rules that could mean major new costs for medical device makers.

Sunshine: CMS outlines 4 changes to physician payment transparency rules

Medicare regulators are looking for feedback on proposed changes to the laws governing transparency in financial relationships between doctors and healthcare companies, warning that the changes may represent a hefty new cost for medical device makers in particular.

Error: You have no payments from pharma

July 22, 2014 by MassDevice

Doctors checking a soon-to-be-unveiled federal website that will publicly list drug company payments are encountering error messages if they have not accepted industry money.

Error: You have no payments from pharma
(David Sleight/ProPublica)

by Charles Ornstein, ProPublica

The federal government has a word for physicians who don't have financial relationships with pharmaceutical and medical device manufacturers: "Error."

Welch Allyn leads $7M round for Cardiac Insight

July 22, 2014 by Brad Perriello

A $7 million funding round for Cardiac Insight, 1st reported by MassDevice.com, was led by Welch Allyn and includes exclusive global distribution rights, the companies said yesterday.

Welch Allyn leads $7M round for Cardiac Insight

Boston Scientific aims to simplify intravascular imaging with Polaris

July 22, 2014 by Arezu Sarvestani

The Massachusetts medtech giant launches commercial efforts for its Polaris imaging software, an upgrade to the iLab system that aims to be "smart, fast and accurate."

Boston Scientific aims to simplify intravascular imaging with Polaris

Boston Scientific (NYSE:BSX) today announced the commercial launch of its Polaris imaging software, an upgrade to the company's iLab system that aims to make intravascular imaging simpler and more powerful.

SEC dings Misonix investor relations exec for insider trading

July 22, 2014 by Brad Perriello

The U.S. Securities & Exchange Commission dings an outside investor relations executive for Misonix with insider trading charges.

SEC dings Misonix investor relations exec for insider trading

The U.S. Securities & Exchange Commission today dinged an outside investor relations executive with insider trading charges, accusing Kevin McGrath of Cameron Assoc. of "trading on confidential information he learned about two clients while he helped prepare their press releases."

Press Release: St. Jude Medical announces CE Mark approval and 1st use of the FlexAbility ablation catheter

July 22, 2014 by MassDevice

European approval of next-generation ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio.

Press Release: St. Jude Medical announces CE Mark approval and first use of the FlexAbility ablation catheter

St. Jude lands E.U. nod for flexible ablation catheter

July 22, 2014 by Arezu Sarvestani

Minnesota medtech giant St. Jude Medical touts 1st use of its FlexAbility ablation catheter after landing approval from European regulators.

St. Jude lands E.U. nod for flexible ablation catheter

European regulators put their stamp of approval on St. Jude Medical's (NYSE:STJ) new FlexAbility ablation catheter, paving the way to 1st use of the next-generation device.

Boston Scientific loses bids to exclude testimony in pelvic mesh trials

July 22, 2014 by Brad Perriello

A federal judge denies bids by Boston Scientific to exclude the testimony of a physician and a regulatory expert in the multi-district litigation filed over its pelvic mesh products.

Boston Scientific loses bids to exclude testimony in pelvic mesh trials
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp